What is happening with GW Pharmaceuticals?
Mia Ramsey DUBLIN, May 5, 2021 /PRNewswire/ — Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”), a leader in the science, development and commercialization of cannabinoid-based prescription medicines.
Who bought out GW Pharmaceuticals?
Jazz Pharmaceuticals
In the first marijuana industry buyout of 2021, Jazz Pharmaceuticals (NASDAQ:JAZZ) agreed to pay a hefty $7.6 billion to acquire GW Pharmaceuticals (NASDAQ:GWPH), a developer of cannabis-based medications.
How much did Jazz Pharmaceuticals pay for GW Pharmaceuticals?
The two companies announced Wednesday that Jazz’s acquisition of GW has been completed. This brings the $7.6 billion cash-and-stock deal, first announced in early February, to a close.
Is GW Pharmaceuticals an American company?
GW Pharmaceuticals is a British pharmaceutics company known for its multiple sclerosis treatment product nabiximols (brand name, Sativex) which was the first natural cannabis plant derivative to gain market approval in any country.
Is GWPH a buy or sell?
Consensus Rating The company’s average rating score is 2.00, and is based on no buy ratings, 8 hold ratings, and no sell ratings.
Who owns Jazz Pharmaceuticals?
Bruce C. Cozadd
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a biopharmaceutical company based in Ireland. It was founded in 2003….Jazz Pharmaceuticals.
| Type | Public company |
|---|---|
| Headquarters | Waterloo Exchange, Waterloo Road, D04 E5W7, Dublin, Ireland |
| Area served | Worldwide |
| Key people | Bruce C. Cozadd (Chairman & CEO) |
Where did my GW Pharmaceuticals stock go?
On Friday, shareholders of GW Pharmaceuticals (NASDAQ:GWPH) approved its acquisition by a subsidiary of Jazz Pharmaceuticals (NASDAQ:JAZZ), both companies announced in a joint press release. The approval is one of the final steps required to fuse the pair together.
How much is a share of GW Pharmaceuticals?
GW Pharmaceuticals Plc (GWPH)
| Prev Close | 219.28 |
|---|---|
| Open | 219.31 |
| Day Low/High | 218.60 / 219.54 |
| 52 Wk Low/High | 67.98 / 144.00 |
| Volume | 1.46M |
Did GW Pharmaceuticals get bought out?
DUBLIN , May 5, 2021 /PRNewswire/ — Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”), a leader in the science, development and commercialization of cannabinoid-based prescription medicines.
Should I keep GWPH?
The consensus among Wall Street equities research analysts is that investors should “hold” GW Pharmaceuticals stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GWPH, but not buy additional shares or sell existing shares.
Why is GWPH going down?
Shares of GW Pharmaceuticals PLC gwph slumped 12% Friday, after the company swung to a loss in the second quarter, hurt by the effect of the coronavirus pandemic. The company posted a loss of $8.8 million, or 2 cents a share, for the quarter, after income of $79.7 million in the year-earlier period.
What is the stock symbol for GW Pharmaceuticals?
GWPH
Shares in GW Pharmaceuticals are traded as American Depositary Receipts or ADRs on the NASDAQ stock market under the ticker symbol: GWPH.
Who is the CEO of GW Pharmaceuticals?
LONDON and CARLSBAD, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that Justin Gover, GW’s Chief Executive
What is GW Pharmaceuticals’ stock price and ticker symbol?
What is GW Pharmaceuticals’ stock symbol? GW Pharmaceuticals trades on the NASDAQ under the ticker symbol “GWPH.” What is GW Pharmaceuticals’ stock price today? One share of GWPH stock can currently be purchased for approximately $218.96.
Did Jazz Pharmaceuticals acquire GW Pharmaceuticals plc?
DUBLIN , May 5, 2021 /PRNewswire/ — Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”), a leader in the science, development and commercialization of cannabinoid-based prescription medicines.
Should you hold GW Pharmaceuticals (gwph) stock?
The consensus among Wall Street research analysts is that investors should “hold” GW Pharmaceuticals stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GWPH, but not buy additional shares or sell existing shares.
